Users of Ozempic and other drugs are shunning items like energy drinks and salty snacks, research shows. But there are ...
One in eight people living in the United States has taken a GLP-1 medication — such as Ozempic, Mounjaro, or Zepbound — for ...
With three meds approved for weight management and several on the way, these may make a dent in the obesity epidemic.
Metsera has linked its GLP-1 drug candidate to weight loss of up to 11.3% after 12 weeks, encouraging the biotech to use some ...
Startup Virta Health saw 60% revenue growth last year, topping $100 million, driven by demand for its employer weight loss ...
People lose weight via three primary methods: diet and exercise, weight loss surgery and GLP-1 weight loss drugs. The ...
Patients with overweight or obesity who used maridebart cafraglutide experienced significant weight loss at 1 year, according ...